Dudum Andrew 的 Form 4/A 修正申報
修正Hims & Hers Health, Inc.（HIMS），2025/1/23 申報
- 申報編號
- 0001773751-25-000014
- 申報時間
- 2025/1/23
- 交易日
- 2025/1/16
- 申報延遲
- 7 天
- 10b5-1 計畫
- 有勾選
- 原始申報日
- 2025/1/21
這份申報列了 2 筆衍生性交易。沿用原件裡沒有重述的 7 筆交易。公開市場賣出合計 $227.1 萬。交易後 7 天申報。
這份修正申報重述了 0001773751-25-000012（2025/1/21 申報）的一部分，沒有重述的交易仍然有效，列在下面。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Dudum AndrewCIK 0001837796 | 董事、高階主管（執行長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
這份申報沒有這一類的交易。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/1/16 | Class A Common Stock | M行使選擇權處分 | −17,001 | $0.00 | $0 | 170,014 | 直接 | |
| 2025/1/16 | Class A Common Stock | M行使選擇權處分 | −16,667 | $0.00 | $0 | 1,548,068 | 直接 |
沿用原件的交易
這份修正申報只重述了原件的一部分。原件其他的交易仍然有效，網站的交易表把它們算在這份修正申報底下。
來自 0001773751-25-000012（2025/1/21 申報）。
非衍生性證券（表 I）
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/1/16 | Class A Common Stock | M行使選擇權取得 | +33,668 | $2.43 | +$81,813.24 | 64,378 | 直接 | |
| 2025/1/16 | Class A Common Stock | S賣出處分 | −25,915 | $27.03F2 | −$700,482.45 | 38,463 | 直接 | |
| 2025/1/16 | Class A Common Stock | S賣出處分 | −7,753 | $27.22F3 | −$211,036.66 | 30,710 | 直接 | |
| 2025/1/16 | Class A Common Stock | S賣出處分 | −1,692 | $27.04F4 | −$45,751.68 | 29,018 | 直接 | |
| 2025/1/16 | Class A Common Stock | S賣出處分 | −1,100 | $27.40F3 | −$30,140 | 27,918 | 直接 | |
| 2025/1/16 | Class A Common Stock | S賣出處分 | −40,553 | $26.96F5 | −$1,093,308.88 | 482,311 | 間接 | |
| 2025/1/16 | Class A Common Stock | S賣出處分 | −6,981 | $27.28F6 | −$190,441.68 | 475,330 | 間接 |
原件的附註
這幾筆交易的價格在原件上引用的附註。
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.70 - $27.115. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.12 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 2 筆交易的價格引用這則附註。
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.01 - $27.085. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.72 - $27.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.125 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The form is being revised to show the correct option award being used for this transaction.
- F2
The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
- F3
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
- F4
The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.